Combination of immune checkpoint inhibitors and anti-angiogenic agents: An emerging strategy for cancer therapy
Yunyi Li, Lu Yang, Liu Zd
Topics & Concepts
ImmunotherapyTumor microenvironmentClinical trialCombination therapyMedicineCancerImmune systemCancer therapyImmune checkpointCancer immunotherapyImmunologyPharmacologyInternal medicineCancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentCAR-T cell therapy research